ES8203882A1 - Un procedimiento para la preparacion de 1-(8-quinole- il)-2-pirrolidinona y sus sales de adicion de acido - Google Patents

Un procedimiento para la preparacion de 1-(8-quinole- il)-2-pirrolidinona y sus sales de adicion de acido

Info

Publication number
ES8203882A1
ES8203882A1 ES497242A ES497242A ES8203882A1 ES 8203882 A1 ES8203882 A1 ES 8203882A1 ES 497242 A ES497242 A ES 497242A ES 497242 A ES497242 A ES 497242A ES 8203882 A1 ES8203882 A1 ES 8203882A1
Authority
ES
Spain
Prior art keywords
formulations
medicine
compound
synthesis
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES497242A
Other languages
English (en)
Other versions
ES497242A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of ES8203882A1 publication Critical patent/ES8203882A1/es
Publication of ES497242A0 publication Critical patent/ES497242A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/40—Nitrogen atoms attached in position 8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Catalysts (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

PROCEDIMIENTO DE OBTENCION DE 1-(8-QUINOLEIL)-2-PIRROLIDINONA DE SUS SALES DE ADICION DE ACIDO. CONSISTE EN CICLISAR UN COMPUESTO (I) O (II) EN PRESENCIA DE UN CATALIZADOR QUE SEA O INCLUYA UN HIDRURO, HIDROXIDO O ALCOXIDO DE METAL ALCALINO, HIDRURO DE POTASIO, HIDROXIDO DE POTASIO O TERC-BUTOXIDO DE POTASIO. EL DICHO CATALIZADOR ES DE TRANSFERENCIA DE FASES, SIENDO CLORURO DE TRIETILBENCILAMONIO. SE OBTIENE EL COMPUESTO (III).
ES497242A 1979-11-30 1980-11-28 Un procedimiento para la preparacion de 1-(8-quinole- il)-2-pirrolidinona y sus sales de adicion de acido Granted ES497242A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB7941409 1979-11-30

Publications (2)

Publication Number Publication Date
ES8203882A1 true ES8203882A1 (es) 1982-04-01
ES497242A0 ES497242A0 (es) 1982-04-01

Family

ID=10509524

Family Applications (1)

Application Number Title Priority Date Filing Date
ES497242A Granted ES497242A0 (es) 1979-11-30 1980-11-28 Un procedimiento para la preparacion de 1-(8-quinole- il)-2-pirrolidinona y sus sales de adicion de acido

Country Status (18)

Country Link
US (1) US4366158A (es)
EP (1) EP0030023A3 (es)
JP (1) JPS5699475A (es)
KR (1) KR830004293A (es)
AR (1) AR228442A1 (es)
AT (1) AT375363B (es)
AU (1) AU6495080A (es)
CA (1) CA1156235A (es)
DK (1) DK506480A (es)
ES (1) ES497242A0 (es)
FI (1) FI803704L (es)
GB (1) GB2063868B (es)
GR (1) GR71918B (es)
HU (1) HU185224B (es)
IL (1) IL61580A (es)
IT (1) IT1221040B (es)
NZ (1) NZ195688A (es)
ZA (1) ZA807467B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004000260T2 (de) 2003-07-22 2006-08-24 Arena Pharmaceuticals, Inc., San Diego Diaryl- und arylheteroarylharnstoffderivate als modulatoren des 5-ht2a-serotoninrezeptors, die sich zur prophylaxe und behandlung von damit im zusammenhang stehenden erkrankungen eignen
GB0507198D0 (en) * 2005-04-08 2005-05-18 Sb Pharmco Inc Process for preparing bicyclic compounds
GB0519758D0 (en) * 2005-09-28 2005-11-09 Glaxo Group Ltd Novel process
WO2009074607A1 (en) 2007-12-12 2009-06-18 Glaxo Group Limited Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline
WO2009123714A2 (en) 2008-04-02 2009-10-08 Arena Pharmaceuticals, Inc. Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor
WO2010062321A1 (en) 2008-10-28 2010-06-03 Arena Pharmaceuticals, Inc. Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto
CN109562085A (zh) 2015-06-12 2019-04-02 阿速万科学有限责任公司 用于预防和治疗rem睡眠行为障碍的二芳基和芳基杂芳基脲衍生物
BR112018000728A2 (pt) 2015-07-15 2018-09-04 Axovant Sciences Gmbh resumo método para a profilaxia e/ou tratamento de alucinações visuais em um sujeito com necessidade do mesmo

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4143151A (en) * 1978-07-03 1979-03-06 The Dow Chemical Company Method for treating hyperglycemia in mammals using arylamino benzoic acids

Also Published As

Publication number Publication date
AU6495080A (en) 1981-06-04
HU185224B (en) 1984-12-28
DK506480A (da) 1981-05-31
JPS5699475A (en) 1981-08-10
EP0030023A3 (en) 1981-09-02
NZ195688A (en) 1984-09-28
GB2063868A (en) 1981-06-10
CA1156235A (en) 1983-11-01
ATA582780A (de) 1983-12-15
EP0030023A2 (en) 1981-06-10
FI803704L (fi) 1981-05-31
GR71918B (es) 1983-08-17
IL61580A (en) 1984-06-29
ES497242A0 (es) 1982-04-01
AR228442A1 (es) 1983-03-15
IT1221040B (it) 1990-06-21
IL61580A0 (en) 1980-12-31
IT8050277A0 (it) 1980-11-28
KR830004293A (ko) 1983-07-09
US4366158A (en) 1982-12-28
GB2063868B (en) 1984-02-29
ZA807467B (en) 1982-07-28
AT375363B (de) 1984-07-25

Similar Documents

Publication Publication Date Title
ES485188A1 (es) Procedimiento para preparar 1-piperazina-carboxamidas y car-botiamidas
ZA831452B (en) Cephalosporing derivatives,and a process for their preparation
ZA796651B (en) New amino-pyrimidine-carbanilides, processes for their preparation, medicaments containing these compounds and their use and also diamino-pyrimidinecarbanilides and processes for their preparation
ES473451A1 (es) Un procedimiento para la preparacion de derivados de imida- zol.
ES476106A1 (es) Procedimiento para la preparacion de 4-espectinomicilamina.
ES8306371A1 (es) "un procedimiento para la preparacion de sales de s-adenosilmetionina".
ES8800161A1 (es) Procedimiento para la fabricacion de derivados quinolilglicinamidas
DE2964903D1 (en) 2-lower alkyl-7-substituted-2 or 3-cephem-4-carboxylic acid compounds, processes for their preparation and pharmaceutical compositions containing them
ES8203882A1 (es) Un procedimiento para la preparacion de 1-(8-quinole- il)-2-pirrolidinona y sus sales de adicion de acido
ES8305759A1 (es) "un procedimiento para la preparacion de 1-(1,3-bendodioxol-5-il)-2-pirrolidinona".
AU579295B2 (en) New thiazole derivatives, a process for the preparation thereof and pharmaceutical compositions containing them
IL64839A (en) N-arylmethyl-4-(methylanilino)-5-sulfamoyl-anthranilic acids,a process for their preparation and pharmaceutical compositions containing them
ES445969A1 (es) Un procedimiento de preparacion de la (fluoro-4-trifluorome-tiltio-3-fenil)-1-piperazina.
ES8708213A1 (es) Un procedimiento para preparar un derivado de 1-benzhidril--4-cinamilpiperazina
IE40758B1 (en) New basic enol ethers,their salts,process for their preparation and pharmaceutical preparations containing the same
IE43848L (en) Pharmaceutical compositions
ES8105724A1 (es) Procedimiento para la preparacion de nuevas ureas sustitui- das con radicales basicos
JPS5634625A (en) Antitumorigenic agent
JPS5634624A (en) Central nervous system depressant
ES8306729A1 (es) "procedimiento de obtencion de 2-isopropil pirido (2-1-b) quinazolinas y sus sales no toxicas con actividad antianafilactica".
TH2131B (th) การเตรียมอนุพันธ์ของเบนซิมิดาโซลและสารผสมของสารเหล่านี้

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20010301